Euroasian journal of hepato-gastroenterology

Register      Login

VOLUME 14 , ISSUE 2 ( July-December, 2024 ) > List of Articles

Original Article

Prevalence of Osteosarcopenia and Frailty in Patients with Chronic Liver Disease

Shamim Nazir, Zaigham Abbas, Shaima Amjad, Abeer Altaf, Muhammad Ali Qadeer, Sania Maqbool, Mehreen Siyal, Manesh Kumar

Keywords : Chronic liver disease, DEXA scan, Dynamometer, Frailty, Osteoporosis, Osteopenia, Sarcopenia

Citation Information : Nazir S, Abbas Z, Amjad S, Altaf A, Qadeer MA, Maqbool S, Siyal M, Kumar M. Prevalence of Osteosarcopenia and Frailty in Patients with Chronic Liver Disease. Euroasian J Hepatogastroenterol 2024; 14 (2):156-159.

DOI: 10.5005/jp-journals-10018-1442

License: CC BY-NC 4.0

Published Online: 27-12-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Introduction: Chronic liver disease (CLD) can have a significant impact on the nutritional status of patients. Malnutrition is an under-recognized condition in patients with cirrhosis. Malnutrition increases the incidence and severity of decompensation, increases the risk of infections, and increases mortality. The present study aimed to assess osteosarcopenia and frailty in patients with CLD. Materials and methods: This prospective cross-sectional study included 151 cases of CLD, aged between 18 and 85 years. Anthropometric measurements were performed. Sarcopenia was assessed by handgrip strength using a hand-held dynamometer. Bone mineral density was measured with the help of an office-based DEXA scan (Osteosys). Liver frailty was assessed through performance-based tests. Results: Out of 151 patients, 98 were male (69.5%); mean age was 51.8 ± 13.2. The presarcopenia was seen in 91 (60%) patients, and sarcopenia in 45(30%). Osteopenia was present in 75 (50%) and osteoporosis in 24 (16%). The patients with osteopenia and osteoporosis had a high liver frailty index (LFI) (p-value < 0.001). A significant correlation between body mass index, waist circumference, LFI, calcium level, bilirubin and Child Pugh scores was seen with T and Z scores. Factors associated with low bone mineral density included increasing age and LFI, low calcium and higher PTH. Conclusion: There is a high prevalence of pre-sarcopenia, sarcopenia, osteopenia, osteoporosis and high frailty in our patients with CLD. Early detection and timely intervention in these conditions are important to reduce the associated consequences. All patients with CLD should be assessed for osteosarcopenia and frailty, both at baseline and longitudinally.


PDF Share
  1. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134(6):1655–1669. DOI: 10.1053/j.gastro.2008.03.003.
  2. Ranjan R, Rampal S, Jaiman A, et al. Common musculoskeletal disorders in chronic liver disease patients. Joint diseases and related surgery 2021;32(3):818–823. DOI: 10.52312/jdrs.2021.25.
  3. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019;48(1):16–31. DOI: 10.1093/ageing/afy169.
  4. Kawao N, Kaji H. Interactions between muscle tissues and bone metabolism. Journal of cellular biochemistry 2015;116(5):687–695. DOI: 10.1002/jcb.25040.
  5. Qiu J, Thapaliya S, Runkana A, et al. Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism. Proc Natl Acad Sci USA 2013;110(45):18162–18167. DOI: 10.1073/pnas.1306465110.
  6. Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012;10(2):166–173. DOI: 10.1016/j.cgh.2011.08.028.
  7. Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology 2017;66(2):564–574. DOI: 10.1002/hep.29219.
  8. Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 2015;6(7):e102. DOI: 10.1038/ctg.2015.19.
  9. Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol 2016;65(6):1232–1244. DOI: 10.1016/j.jhep.2016.07.040.
  10. Carey EJ, Lai JC, Wang CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl 2017;23(5):625–633. DOI: 10.1002/lt.24750.
  11. Kim G, Kang SH, Kim MY, et al. Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. PLoS One 2017;12(10):e0186990. DOI: 10.1371/journal.pone.0186990.
  12. Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 1999;10(4):259–264. DOI: 10.1007/s001980050224.
  13. Juby AG, Davis CMJ, Minimaana S, et al. Addressing the main barrier to sarcopenia identification: Utility of practical office-based bioimpedance tools vs. dual energy x-ray absorptiometry (DXA) body composition for identification of low muscle mass in older adults. Canadian geriatrics journal CGJ 2023;26(4):493–501. DOI: 10.5770/cgj.26.626.
  14. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: Scientific review. JAMA 2002;288(15):1889–1897. DOI: 10.1001/jama.288.15.1889.
  15. Lai JC, Sonnenday CJ, Tapper EB, et al. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant 2019;19(7):1896–1906. DOI: 10.1111/ajt.15392.
  16. Spearman C. The proof and measurement of association between two things. Am J Psychol 1904;15(1):72–101. DOI: 10.2307/1412159.
  17. Schober P, Boer C, Schwarte LA. Correlation coefficients: Appropriate use and interpretation. Anesthesia and analgesia 2018;126(5):1763–1768. DOI: 10.1213/ANE.0000000000002864.
  18. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15(2):95–101. DOI: 10.1016/j.jamda.2013.11.025.
  19. Montano-Loza AJ, Meza-Junco J, Baracos VE, et al. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation. Liver Transpl 2014;20(6): 640–648. DOI: 10.1002/lt.23863.
  20. Sinclair M, Gow PJ, Grossmann M, et al. Review article: Sarcopenia in cirrhosis—Aetiology, implications and potential therapeutic interventions. Aliment Pharmocol Ther 2016;43(7):765–777. DOI: 10.1111/apt.13549.
  21. Hanai T, Shiraki M, Nishimura K, et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition 2015;31(1):193–199. DOI: 10.1016/j.nut.2014.07.011.
  22. Haseltine KN, Chukir T, Smith PJ, et al. Bone mineral density: Clinical relevance and quantitative assessment. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2021;62(4):446–454. DOI: 10.2967/jnumed.120.256180.
  23. Geladari E, Alexopoulos T, Kontogianni MD, et al. The presence of myosteatosis is associated with age, severity of liver disease and poor outcome and may represent a prodromal phase of sarcopenia in patients with liver cirrhosis. Journal of clinical medicine 2023;12(9): 3332. DOI: 10.3390/jcm12093332.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.